PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28656194-6	2017	3-Bromo-7-nitroindazole (3-Br-7-NI), a relatively selective nNOS inhibitor, abolished the OGD-induced inhibition of cell viability and the increased expression of ER stress-related proteins, including glucose-regulated protein 78 (GRP78), C/EBP homologous protein (CHOP) and cleaved caspase-12 in PC12 cells, indicating the contribution of excessive nNOS/NO signaling to OGD-induced ER stress.	3-bromo-7-nitroindazole	0-23	nitric oxide synthase 1	Rattus norvegicus	60-64	
28656194-6	2017	3-Bromo-7-nitroindazole (3-Br-7-NI), a relatively selective nNOS inhibitor, abolished the OGD-induced inhibition of cell viability and the increased expression of ER stress-related proteins, including glucose-regulated protein 78 (GRP78), C/EBP homologous protein (CHOP) and cleaved caspase-12 in PC12 cells, indicating the contribution of excessive nNOS/NO signaling to OGD-induced ER stress.	3-bromo-7-nitroindazole	25-34	nitric oxide synthase 1	Rattus norvegicus	60-64	
25636602-4	2015	Therefore the aim of this study was to investigate the effects of chronic 3-bromo 7-nitroindazole (3-Br 7-NI), specific neuronal nitric oxide synthase (nNOS) inhibitor, administration on spatial learning and memory performance in rats using the Morris water maze (MWM) paradigm.	3-bromo-7-nitroindazole	74-97	nitric oxide synthase 1	Rattus norvegicus	152-156	
25636602-6	2015	Daily administration of the specific neuronal nitric oxide synthase (nNOS) inhibitor, 3-Br 7-NI impaired the acquisition of the MWM task.	3-bromo-7-nitroindazole	86-95	nitric oxide synthase 1	Rattus norvegicus	69-73	
22075494-2	2012	The aim of the study was to investigate the neuroprotective potential of 3-bromo-7-nitroindazole (3-BNI), a potent and selective neuronal nitric oxide synthase (nNOS) inhibitor against ER stress and focal cerebral I/R injury associated with comorbid type 2 diabetes in-vivo.	3-bromo-7-nitroindazole	73-96	nitric oxide synthase 1	Rattus norvegicus	129-159	
22075494-2	2012	The aim of the study was to investigate the neuroprotective potential of 3-bromo-7-nitroindazole (3-BNI), a potent and selective neuronal nitric oxide synthase (nNOS) inhibitor against ER stress and focal cerebral I/R injury associated with comorbid type 2 diabetes in-vivo.	3-bromo-7-nitroindazole	73-96	nitric oxide synthase 1	Rattus norvegicus	161-165	
22075494-2	2012	The aim of the study was to investigate the neuroprotective potential of 3-bromo-7-nitroindazole (3-BNI), a potent and selective neuronal nitric oxide synthase (nNOS) inhibitor against ER stress and focal cerebral I/R injury associated with comorbid type 2 diabetes in-vivo.	3-bromo-7-nitroindazole	98-103	nitric oxide synthase 1	Rattus norvegicus	129-159	
22075494-2	2012	The aim of the study was to investigate the neuroprotective potential of 3-bromo-7-nitroindazole (3-BNI), a potent and selective neuronal nitric oxide synthase (nNOS) inhibitor against ER stress and focal cerebral I/R injury associated with comorbid type 2 diabetes in-vivo.	3-bromo-7-nitroindazole	98-103	nitric oxide synthase 1	Rattus norvegicus	161-165